Indian Immunologicals (IIL) has announced a significant breakthrough in veterinary science with the introduction of Raksha-IBR, India’s very first indigenously developed glycoprotein E (gE) deleted DIVA marker vaccine. This innovative solution is designed to combat Infectious Bovine Rhinotracheitis (IBR), a widespread and highly damaging disease in the bovine population.
This new vaccine, Raksha-IBR, offers a ray of hope for the dairy industry by directly tackling critical issues such as infertility, abortions, and a substantial reduction in milk production, all commonly associated with IBR. The Hyderabad-based vaccine manufacturer emphasized the profound impact this disease has on livestock.
The official launch of Raksha-IBR took place during the diamond jubilee celebrations of IIL’s parent organization, the National Dairy Development Board (NDDB), on September 27 in Anand, Gujarat. Dignitaries present included Narendra Pal Gangwar, Secretary to the Centre’s Department of Animal Husbandry and Dairying, NDDB Chairman Meenesh C. Shah, and IIL Managing Director K. Anand Kumar.
IBR, caused by the Bovine Herpes Virus (BHV-1), is prevalent across India. It spreads easily through aerosol transmission and has severe consequences for the reproductive health of cattle. Furthermore, infected bulls can transmit the virus through semen to milch animals. The disease leads to significant economic losses, estimated at a staggering ₹18,000 crore annually, primarily due to reduced milk yield and reproductive failures. Currently, there is no specific treatment available for IBR, making systematic vaccination and stringent biosecurity measures crucial for prevention. A key feature of Raksha-IBR is its ‘DIVA marker’ capability, which allows for the clear differentiation between animals that have been vaccinated and those that have been naturally infected.
Mr. Anand Kumar highlighted the immense research efforts by IIL scientists and NDDB that culminated in this pioneering vaccine. He underscored the importance of boosting productivity across all facets of India’s dairy sector, especially as the nation stands as the world’s largest milk producer. He noted that considerable time and effort are invested in developing superior genetic bull herds, and the IBR virus can tragically negate these advancements, making effective vaccination vital for protecting these valuable assets and ensuring sustained growth in dairy farming.